MXPA02010837A - Compuestos derivados del felbamato. - Google Patents
Compuestos derivados del felbamato.Info
- Publication number
- MXPA02010837A MXPA02010837A MXPA02010837A MXPA02010837A MXPA02010837A MX PA02010837 A MXPA02010837 A MX PA02010837A MX PA02010837 A MXPA02010837 A MX PA02010837A MX PA02010837 A MXPA02010837 A MX PA02010837A MX PA02010837 A MXPA02010837 A MX PA02010837A
- Authority
- MX
- Mexico
- Prior art keywords
- derived compounds
- felbamate
- felbamate derived
- glaucoma
- obesity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invencion se refiere al uso de ciertos derivados del felbamato, para tratar el dolor neuropatico, la obesidad, el glaucoma, la depresion, y trastornos en el estado de animo, asi como otras condiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20214500P | 2000-05-05 | 2000-05-05 | |
PCT/US2001/014594 WO2001085149A2 (en) | 2000-05-05 | 2001-05-04 | Felbamate derived compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02010837A true MXPA02010837A (es) | 2004-02-26 |
Family
ID=22748666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02010837A MXPA02010837A (es) | 2000-05-05 | 2001-05-04 | Compuestos derivados del felbamato. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1282414B1 (es) |
JP (1) | JP2003532672A (es) |
AT (1) | ATE286390T1 (es) |
AU (2) | AU2001261219B2 (es) |
CA (1) | CA2407697A1 (es) |
DE (1) | DE60108241T2 (es) |
ES (1) | ES2231495T3 (es) |
MX (1) | MXPA02010837A (es) |
NZ (1) | NZ522249A (es) |
PT (1) | PT1282414E (es) |
WO (1) | WO2001085149A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10136842A1 (de) * | 2001-07-23 | 2003-02-13 | Schering Ag | GABA¶A¶-Rezeptor-Modulatoren mit NMDA-antagonistischer Aktivität |
WO2009129181A1 (en) * | 2008-04-14 | 2009-10-22 | Concert Pharmaceuticals Inc. | Propanediol-dicarbamate derivatives |
FR2948660B1 (fr) | 2009-07-30 | 2011-08-19 | Oroxcell | Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728728A (en) * | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
AU771936B2 (en) * | 1999-02-09 | 2004-04-08 | University Of Virginia Patent Foundation | Felbamate derived compounds |
-
2001
- 2001-05-04 AU AU2001261219A patent/AU2001261219B2/en not_active Ceased
- 2001-05-04 NZ NZ522249A patent/NZ522249A/en unknown
- 2001-05-04 AU AU6121901A patent/AU6121901A/xx active Pending
- 2001-05-04 WO PCT/US2001/014594 patent/WO2001085149A2/en active IP Right Grant
- 2001-05-04 AT AT01935095T patent/ATE286390T1/de not_active IP Right Cessation
- 2001-05-04 JP JP2001581803A patent/JP2003532672A/ja not_active Withdrawn
- 2001-05-04 PT PT01935095T patent/PT1282414E/pt unknown
- 2001-05-04 CA CA002407697A patent/CA2407697A1/en not_active Abandoned
- 2001-05-04 DE DE60108241T patent/DE60108241T2/de not_active Expired - Fee Related
- 2001-05-04 EP EP01935095A patent/EP1282414B1/en not_active Expired - Lifetime
- 2001-05-04 MX MXPA02010837A patent/MXPA02010837A/es active IP Right Grant
- 2001-05-04 ES ES01935095T patent/ES2231495T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE60108241T2 (de) | 2005-05-25 |
CA2407697A1 (en) | 2001-11-15 |
AU6121901A (en) | 2001-11-20 |
ES2231495T3 (es) | 2005-05-16 |
WO2001085149A2 (en) | 2001-11-15 |
WO2001085149A3 (en) | 2002-05-30 |
EP1282414B1 (en) | 2005-01-05 |
ATE286390T1 (de) | 2005-01-15 |
PT1282414E (pt) | 2005-04-29 |
AU2001261219B2 (en) | 2005-08-25 |
DE60108241D1 (de) | 2005-02-10 |
NZ522249A (en) | 2004-08-27 |
EP1282414A2 (en) | 2003-02-12 |
JP2003532672A (ja) | 2003-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03010232A (es) | Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central. | |
FR2706767B1 (es) | ||
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
WO2002059117A8 (en) | Piperazine- and piperidine-derivatives as melanocortin receptor agonists | |
WO2002059107A8 (en) | Substituted piperidines/piperazines as melanocortin receptor agonists | |
HK1094425A1 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
WO2004069152A3 (en) | Δ4,5 glycuronidase and uses thereof | |
HK1080467A1 (en) | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders | |
GB0111186D0 (en) | Novel compounds | |
HK1051499A1 (en) | Method for treating ocular pain | |
MXPA05011707A (es) | Dihidroquinazolinas sustituidas con propiedades antivirales. | |
NO20035025D0 (no) | Anvendelse av osteopontin for behandling og/eller for å hindre nevrologiskesykdommer | |
IL110943A (en) | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
AU7096201A (en) | Phospholipid derivatives of valproic acid and mixtures thereof | |
DK1463735T3 (da) | Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider | |
EP1441724B8 (en) | Methods of increasing endogenous testosterone levels | |
MXPA03007653A (es) | Uso de lp82 para tratar trastornos hematopoyeticos. | |
CY1107039T1 (el) | Αναστολεις τριπεπτιδυλ πεπτιδασης | |
MXPA04000446A (es) | 4-aminociclohexanoles sustituidos. | |
MXPA04003544A (es) | Benzotriazepinas como ligandos del receptor de gastrina y colecistocinina. | |
AU6121901A (en) | Felbamate derived compounds | |
TW200505435A (en) | Treatment of ocular disorders | |
UA85187C2 (en) | 2-aminobenzoyl derivatives | |
AU2003283011A1 (en) | Spirocyclopropyl amides and acids and their therapeutic applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |